Cosmo to Host Investor Day on April 9, 2025
Dublin, Ireland--(Newsfile Corp. - February 12, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (Cosmo) is pleased to announce that it will host an Investor Day on Wednesday, April 9, 2025.
The live event will be held at the Hotel Park Hyatt at Beethovenstrasse 21 in 8002 Zurich, Switzerland. The presentation will begin at 11:00am CET and will be followed by lunch.
Cosmos Investor Day event will include presentations from the Management team on Cosmos R&D pipeline, long-term strategic initiatives and growth opportunities. CEO Giovanni Di Napoli and the executive team are looking forward to the subsequent Q&A session with investors, analysts and media representatives.
The link with registration details (for those attending in person) along with the live webcast details (for those joining online) will be made available under the Events & Presentations section of Cosmos website. A replay of the webcast will be available after the event.
About Cosmo
Cosmo Pharmaceuticals N.V. is committed to revolutionizing healthcare and transforming peoples lives by researching and developing innovative products that tackle unfulfilled healthcare demands. As a pharmaceutical company, Cosmo is active in the areas of Healthtech/AI, dermatology, gastroenterology and contract manufacturing & development. For the commercialization and distribution of its products, Cosmo collaborates with leading partners worldwide, including Medtronic and Sun Pharma. Founded in 1997, Cosmo is headquartered in Dublin (Ireland) and has offices also in San Diego (USA), and Lainate/Rome/Catania (Italy). The Company had approximately 330 employees at the end of 2024, all dedicated to making a significant impact in the field of healthcare. For more information, please visit www.cosmopharma.com.
Upcoming Events
| 2024 Full-Year Results (unaudited) | March 6, 2025 |
| J.P. Morgan European Opportunities Forum, London | March 12, 2025 |
| 2024 Annual Report Publication | March 20, 2025 |
| 26th Kepler Cheuvreux Swiss Seminar, Zurich | March 20, 2025 |
| Life Sciences Conference, Amsterdam | April 2-3, 2025 |
| Investor Day 2025 | April 9, 2025 |
| 2025 Half-Year Results and Report | July 23, 2025 |
For information requests about Cosmos Investor Day 2025, please contact:
Hazel Winchester, Head of Investor Relations
Cosmo Pharmaceuticals N.V.
Tel: +353 1 817 03 70
[email protected]
Attachments
250212_Cosmo_Announcement_Investor Day 2025_english_final
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/240533
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla Nears Unveiling of Radical New ‘Flying’ Roadster - The Information
- Fox upgraded to overweight as Roku deal, ad strength lift outlook
- SpaceX completes record $60 billion acquisition of AI coding platform Cursor
Create E-mail Alert Related Categories
Newsfile, Press ReleasesRelated Entities
JPMorgan, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share